Introduction {#Sec1}
============

Magnetic resonance imaging (MRI) is playing an increasing role in suspected myocarditis, providing information on cardiac anatomy and function as well as typical signs of inflammation. These signs include an increase in tissue fluid or relative oedema \[[@CR1]--[@CR3]\], increased perfusion and vascular permeability of the myocardium at rest, reflected in the relative enhancement at MRI \[[@CR1], [@CR2], [@CR4]--[@CR7]\], and the loss of muscle cells and replacement with scar tissue, seen as late enhancement \[[@CR2], [@CR5], [@CR8]--[@CR10]\]. Together, the changes seen at MRI allow one to diagnose myocarditis and monitor its course. Nevertheless, our experience and published studies suggest that the role of MRI in general and the reliability of the different parameters for diagnosing inflammation are not well established. Having examined a relatively large group of patients by MRI for whom immunohistological findings in biopsy specimens are available to serve as an accurate indicator of the presence of myocardial inflammation, we performed a retrospective analysis in an attempt to create a sound basis for the diagnosis of myocarditis by MRI.

Patients and methods {#Sec2}
====================

Patients {#Sec3}
--------

The study included 131 patients. There were 85 men and 46 women ranging in age from 21 to 79 years with a mean age of 44.9 ± 13.2 years.

All patients had a preliminary diagnosis of myocarditis with a clinical indication for cardiac MRI and myocardial biopsy for immunohistological examination. The patients were included in the study only if MRI was performed within 2 weeks of the onset of clinical symptoms.

Follow-up MRI results were not included in the analysis; only the first MRI examination was analysed in patients who underwent serial MRI.

The study group of patients with proven acute myocarditis was defined by the presence of histologically and immunohistologically proven inflammatory infiltration; all other patients included served as controls.

Materials and methods {#Sec4}
---------------------

The diagnostic performance of MRI in confirming or ruling out myocarditis was evaluated by retrospectively analysing cardiovascular MRI and immunohistology of myocardial biopsies. We correlated the MRI findings with immunohistology because it is a more sensitive indicator of an inflammatory process than histological examinations, which are subject to a high sampling error.

For comparison of the two methods, the three features used for diagnosing myocarditis by MRI \[[@CR6]\]---relative enhancement, relative water content and late enhancement, each measured during clinical routine MRI---correlated with the immunohistological findings in right ventricular myocardial biopsy specimens. According to the International Society and Federation of Cardiology classification, immunohistology is the more crucial than histology. According the Dallas-Classification the diagnosis of a myokarditis requires a inflammatory infiltration and a necroses of the myocytes. Additional the Dallas-Classification distinguish the borderline Myocarditis with few inflammatory cells and without a necroses of the myocytes. In our study we considerated the borderline myocarditis as a myocarditis.

Magnetic resonance imaging {#Sec5}
--------------------------

All patients were examined on whole-body MRI with a field strength of 1.5 Tesla (Genesis Signa, General Electric Medical Systems, Milwaukee, WI, USA). The examinations were performed with two coils, a volume coil (body coil) and a surface coil (cardiac coil). Details of the sequences and techniques used are summarised in Table [1](#Tab1){ref-type="table"}. Since the body coil has a rather homogeneous signal reception profile, this coil was used for measuring the relative signal intensities of myocardium and skeleton muscle. Thus, the inhomogeneous signal profile of the cardiac surface coil was avoided. Table 1Schedule with details of the sequences and techniques, which are used in this studyRelative enhancementRelative water contentLate enhancementMRI techniqueFSE (fast spin echo)STIR (short tau inversion recovery)IRGE (inversion recovery gradient echo)Sequence typeT1-weighted spin echoT2-weighted triple inversion recoveryT1-weighted inversion recovery gradient echoCoilBodyBodyCardiacContrast agentContrast-enhancedNonenhancedContrast-enhancedBreathingNormal breathingBreath-holdBreath-holdTriggeringProspective ECG triggeringProspective ECG triggeringProspective ECG triggeringTR (ms)Depending on RRDepending on RR5.5TE (ms)20641.4IT (ms)150140180--240ET32321Matrix (pixels)256\*256256\*256256\*192FOV (cm)38\*3838\*3835\*35SL (mm)20208Spacing (mm)220NEX112*TR* time to repetition, *TE* time to echo, *IT* inversion time, *ET* echotrain, *FOV* field of view, *SL* slice thickness, *NEX* number of excitations

The analysis was performed in routine clinical fashion by two diagnostic radiologists in consensus; they each had extensive experience in cardiac MRI .

Relative enhancement {#Sec6}
--------------------

Relative enhancement \[[@CR6]\] was calculated quantitatively from T1-weighted spin echo images obtained before and after intravenous administration of 0.1 mmol of gadolinium-based contrast agent per kg body weight (Magnevist^®^ Schering, Germany) with the injection-speed of 2 ml/s. The time interval between injection and imaging was 15 s. Here, myocardial signal intensities were calculated from five unenhanced axial slices and the corresponding five postcontrast slices. Two regions of interest (ROIs) were defined on unenhanced images: one ROI encompassing the left ventricular myocardium and another ROI in the musculus erector spinae (Fig. [1](#Fig1){ref-type="fig"}). The ROIs defined on the precontrast images were transferred 1:1 to the postcontrast images to ensure measurement of signal intensities in identical myocardial and skeletal muscle regions for calculation of relative enhancement. The resulting measurement values correspond to the signal intensities of the respective tissues modulated by differences in contrast medium uptake. Next, absolute enhancement was calculated for myocardium and skeletal muscle using the following formula: Fig. 1Two axial slices before (top) and after (bottom) contrast medium administration. The yellow lines encircle typical ROIs used in our study. The latissimus dorsi muscle was used as reference$$\documentclass[12pt]{minimal}
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Relative enhancement was calculated as the mean of the relative enhancements of all five slices. Based on current study data, the cut-off value for abnormal relative enhancement is 4.

Relative water content {#Sec7}
----------------------

While relative enhancement is determined from axial images of the heart, we quantified the relative water content \[[@CR6]\] or relative myocardial oedema ratio using three short-axis slices perpendicular to the interventricular septum acquired with a fat-saturated T2-weighted triple-inversion recovery sequence. A circular ROI was defined encompassing the left ventricular myocardium in all three planes. Signal intensity of skeletal muscle was measured in the musculus erector spinae (Fig. [2](#Fig2){ref-type="fig"}). Drawing the ROI in skeletal muscle is limited by poor demarcation of the muscle from adjacent tissue on fat-saturated T2-weighted images; therefore, we used furthermore a T1-weighted sequence without fat supression in the same orientation to improve visualisation of the myocardium and skeletal muscle. The ROIs were transferred 1 : 1 to the corresponding T2-weighted sequences, allowing measurement of signal intensities in the anatomically correct positions. The measured signal intensities were used to calculate relative water content as follows: Fig. 2Short-axis view perpendicular to the interventricular septum. The ROIs are outlined. Here, the pectoralis major muscle is used as reference. In this case we have measured a relative edema with the value: 2,4$$\documentclass[12pt]{minimal}
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A mean value of relative water content was calculated from the values calculated for each of the three planes. Based on the results of earlier studies, relative water content \<2 is considered normal, while values of 2 or greater are considered to indicate suspect findings.

Late enhancement {#Sec8}
----------------

A contrast-enhanced T1-weighted inversion recovery gradient echo sequence was used to evaluate late enhancement \[[@CR6]\]. Four-chamber, three-chamber and two-chamber views as well as 8--10 short-axis views of the left ventricle were obtained to determine late enhancement. Images were acquired 20 min after contrast medium administration to capture persisting late enhancement, which is of interest here. Positive late enhancement is characterised by an area of increased signal intensity (hyperintensity). That parameter was analyzed visually and not quantitatively (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Short-axis view of the left ventricle obtained 10 min after administration of contrast medium. There is an area of suspect subepicardial focal hyperintensity encircled by a yellow line

Statistical analysis {#Sec9}
--------------------

Dichotomous or non-metrical data were statistically analysed using the Chi-squared test according to Pearson, and results were verified using Fisher's exact test. In addition, logistic regression was used to identify correlations and calculate odds ratios predicting the likelihood of a variable affecting the result.

Metric results for relative enhancement and relative water content were presented in box-plot diagrams.

Results {#Sec10}
=======

Immunohistology confirmed myocardial inflammation in 82 of the 131 patients examined and excluded disease in 49 patients. The statistical results are summarised in Table [2](#Tab2){ref-type="table"}. Table 2Comparison of our results with those oft wo recently published studiesResults of present studyGutberlet et al. Radiology 2008 (9)Abdel- Aty et al. J Am Coll Cardiol 2005 (3)Relative enhancement Sensitivity (%)48.86380Specificity (%)73.88668Positive predictive value (%)78.48674Negative predictive value (%)42.56375Accuracy (%)57.37274Relative water content Sensitivity (%)58.36784Specificity (%)57.16974Positive predictive value (%)73.17478Negative predictive value (%)40.76081Accuracy (%)57.96779Late enhancement Sensitivity (%)30.62744Specificity (%)88.180100Positive predictive value (%)83.96578Negative predictive value (%)38.54462Accuracy (%)49.64971

Relative enhancement {#Sec11}
--------------------

There was a significant correlation between relative enhancement and immunohistological proof of myocarditis with *p* = 0.016 (Pearson's Chi-squared test) or *p* = 0.02 (Fisher's exact test). Mean relative enhancement was 4.4 with a standard deviation of ±2.17 for the subgroup of patients with proven myocarditis and 3.78 with a standard deviation of ± 2.68 for those without proven disease (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4Relative enhancement in the relationship with the results of immunohistology. Box-plot diagram illustrating the distribution of relative enhancement values in patients with negative immunohistology for myocarditis and those positive for the disease (including borderline myocarditis)

Relative water content {#Sec12}
----------------------

Our analysis revealed no significant correlation between relative water content and myocarditis. The results of the statistical analysis are presented in Table [2](#Tab2){ref-type="table"} and Fig. [5](#Fig5){ref-type="fig"}. We calculated the following values: *p* = 0.101 (Pearson's Chi-squared test) and *p* = 0.13 (Fisher's exact test). Mean values and standard deviations were 2.02 ± 0.34 for patients with myocarditis and 1.99 ± 0.48 for patients without immunohistologically proven myocarditis. Fig. 5Relative water content in the relation with the results of immunohistology. Box-plot diagram illustrating the distribution of relative water content in patients with negative immunohistology for myocarditis and those positive for the disease (including borderline myocarditis)

Late enhancement {#Sec13}
----------------

Our results show a significant correlation between late enhancement and myocarditis with the following values: *p* = 0.021 (Pearson's Chi-squared test) and *p* = 0.027 (Fisher's exact test). The results are summarised in Table [2](#Tab2){ref-type="table"}.

In addition, the three parameters were evaluated in combination. In the logistic regression analysis, myocarditis was defined as a positive immunohistological test or a borderline positive test.

All parameters investigated showed significant differences (*p* = 0.05). The odds ratios for relative enhancement and late enhancement were 2.4 and 2.8, respectively, for the presence of myocarditis versus absence of myocarditis.

The sensitivity, specificity and accuracy calculated for the use of all three parameters---relative oedema, relative enhancement and late enhancement---were 39,3%, 91,3% and 62,7% respectively.

The results demonstrated significant differences with values of *p* = 0.013 (Pearson's Chi-squared test) and *p* = 0.022 (Fisher's exact test), which are below the assumed level of significance of *p* = 0.05.

Discussion {#Sec14}
==========

Relative enhancement {#Sec15}
--------------------

The relative enhancement was calculated quantitatively from T1-weighted spin echo images obtained before and after intravenous administration of 0.1 mmol of gadolinium-based contrast agent per kg body weight (Magnevist^®^ Schering, Germany) with the injection-speed of 2 ml/s. The time interval between injection and imaging was 15 s. Here, myocardial signal intensities were calculated from five unenhanced axial slices and the corresponding five postcontrast slices. Two regions of interest (ROIs) were defined on unenhanced images: one ROI encompassing the left ventricular myocardium and another ROI in the musculus erector spinae

Since the body coil has a rather homogeneous signal reception profile, this coil was used for measuring the relative signal intensities of myocardium and skeleton muscle. Thus, the inhomogeneous signal profile of the cardiac surface coil was avoided.

In our study, relative enhancement has a sensitivity of only 48.8% for detecting immunohistologically proven acute myocarditis, which is low compared with data reported in the literature These results suggest that relative enhancement alone is not a reliable diagnostic criterion or screening test for acute myocarditis \[[@CR1], [@CR2]\]. The negative predictive value and accuracy are also low at 42.5% and 42.5%, respectively. On the other hand, specificity and positive predictive value are relatively high (73.8% and 78.4%, respectively) and similar to the values reported from comparable studies. Higher values were found by Gutberlet et al. \[[@CR2]\]. One can only speculate why our results are poorer. One possible explanation is the difference in the number of patients examined: 131 in our study versus 83 in the study by Gutberlet et al. and 47 in the study by Abdel-Aty et al. \[[@CR1]\]. These differences might lead to greater variance in the data and hence affect the results. The discrepancy may also be due to the fact that Gutberlet et al. only investigated patients with chronic myocarditis. It is conceivable that myocardial inflammation starting out as a focal lesion may extend throughout the myocardium as the condition becomes chronic. This assumption is confirmed by the results reported by Laissy et al. showing focal enhancement within the first 7 days after the onset of symptoms and diffuse relative enhancement further along the course \[[@CR7]\]. As our patients were examined at the acute stage within 2 weeks of the onset of clinical symptoms, it is conceivable that the signal enhancement in an early focus of myocardial inflammation is compensated for by the normal signal intensity of surrounding healthy myocardial tissue. This is because we calculated a mean value of relative enhancement from the signal intensities measured throughout the myocardium visible on the respective images. This method may lead to a normal MRI result in patients with immunohistologically proven myocarditis. A third possible explanation is that different patient selection criteria were used, which might in particular explain the difference in results between our study and that of Abdel-Aty et al., who examined patients who potentially had myocarditis and completely healthy volunteers without symptoms. On the other hand, our entire study population consisted of individuals with a high clinical suspicion of acute myocarditis. As a result, our controls were patients who were immunohistologically negative for acute myocarditis. This means that we had no definitive evidence for the absence of myocarditis in the control patients as immunohistology has low sensitivity because of a relatively high sampling error of endomyocardial biopsy, which may explain the relatively moderate sensitivity of relative enhancement in our study. It is of note that in the study of Abdel-Aty et al. myocardial biopsies were obtained in only two patients, which might also have distorted the results because no gold standard diagnosis was available for most of the patients and definitive proof of myocarditis was not available for the patients with relative enhancement at MR \[[@CR1]\].

In our study, the group of patients with immunohistologically proven myocarditis had a mean relative enhancement of 4.4 with a standard deviation of ±2.17 versus 3.78 ± 2.68 in the patients with negative immunohistology; the difference between the two groups is not significant. These values are comparable to those found by Gutberlet et al., whereas Abdel-Aty et al. reported a mean relative enhancement in diseased patients of 6.8 with a standard deviation of ±4.0. The difference may be due to the small number of cases examined by Abdel-Aty et al. or the fact that they examined asymptomatic healthy individuals as controls. The latter point alone does not explain the higher mean value of relative enhancement as such but the examination of asymptomatic patients as controls might explain the clearer separation of the two groups in the study of Abdel-Aty et al. compared with a control group consisting of symptomatic patients with suspected myocarditis in our study.

Logistic regression taking into account age and sex revealed no significant correlation between relative enhancement and myocarditis with *p* = 0.188. The odds ratio is 2.4; in other words, there is a 2.4-fold higher chance of relative enhancement being positive in patients with myocarditis versus patients without myocarditis. This is not a hard indicator but is meaningful as a clue in conjunction with other findings. In conclusion, relative enhancement alone is not a sufficient diagnostic parameter for myocarditis, and our results in acute myocarditis are even poorer than published data on chronic myocarditis \[[@CR7]\]. Nevertheless, relative enhancement is useful as one of several criteria in diagnosing myocarditis.

Relative water content {#Sec16}
----------------------

The relative water content we found in our patients with proven myocarditis is below that reported by other authors \[[@CR1], [@CR2]\]. Again, the discrepancies may be due to the problems outlined above (different numbers of patients, selection criteria, lack of proof of disease by endomyocardial biopsy); in addition, general problems associated with the measurement of water content may play a role. When there is oedema, the fluid content of tissue is increased. Most of the fluid comes from the blood vessels. Extravasation may be caused by inflammatory processes in the setting of myocarditis or might be due to inflammatory or destructive vasculopathies. Examples of vessel diseases include vasculitis or microangiopathy in diabetes mellitus. The results are also influenced by the fact that relative water content is calculated in relation to that of skeletal muscle. If there is additional oedema of the skeletal muscle of whatever aetiology, the MRI result for relative water content will be pseudonormal. Investigating the distribution of relative enhancement in myocardium and skeletal muscle in patients with myocarditis, Laissy et al. found increased enhancement of both the myocardium and peripheral skeletal muscle within the first 7 days after onset of symptoms, suggesting that there is either systemic inflammation or involvement of skeletal muscle \[[@CR7]\]. This might also hold true for relative oedema.

In summary, relative water content alone is even less suitable for diagnosing myocarditis compared with relative enhancement. Relative water content may be interpreted as a clue pointing to the disease but, based on our results, this parameter does not allow more concrete diagnostic conclusions to be drawn.

Late enhancement {#Sec17}
----------------

Late enhancement is the only one of the three MRI parameters for which we found a comparable or even higher statistical significance compared with the study of chronic myocarditis by Gutberlet et al. However, our results are again poorer than those reported by Abdel-Aty et al. Late enhancement has a high specificity compared with relative enhancement and relative water content, while sensitivity is low, rendering this parameter superior to the other two MRI criteria for confirming suspected disease with the low sensitivity precluding the use of this parameter for detecting myocarditis, e.g. in a screening test.

There are several possible explanations for the low sensitivity of late enhancement. Late enhancement, or the persistence of contrast agent in the interstitial space, occurs not only during acute inflammation but also when there is remodelling during healing or may reflect scar tissue or fibrosis as late sequelae of acute myocarditis \[[@CR11]\]. It is conceivable that, despite symptomatic disease, the immunohistological examination may be positive before an organised focus of inflammation becomes morphologically apparent or before there is myocyte loss with subsequent scar formation or fibrosis, conditions that are associated with contrast medium extravasation into the interstitial space seen as late enhancement on MR images. Hence, it can be assumed that cell loss has not yet occurred in acute myocarditis and there is no necrosis or scar tissue to produce late enhancement. Late enhancement significantly correlates with immunohistologically proven myocarditis in our study (*p* = 0.021 or *p* = 0.027). The odds ratio of approx. 2.8 suggests that the probability of seeing late enhancement in patients with myocarditis has the highest probability of all three MRI criteria investigated. Nevertheless, late enhancement alone does not provide a reliable diagnostic criterion for myocarditis.

Combining all three MRI parameters, a positive result for one of the three was found to have a sensitivity of 39,3% with the highest specificity of 91.3% being observed when all three criteria were positive.

Our results suggest that all MRI criteria should be used in combination to arrive at a well-founded conclusion regarding the presence of myocarditis, which is notoriously difficult to diagnose. A positive MRI result may thus serve as a basis for ordering further diagnostic tests. If all three MRI parameters are positive in a patient with the classical clinical symptoms, a diagnosis of myocarditis can be made with a high degree of specificity.

Limitations {#Sec18}
-----------

In our study, endomyocardial biopsy specimens were sampled from different septal regions although some earlier publications already recommended targeted biopsy from potential sites of inflammation suggested by late enhancement on MR images \[[@CR5], [@CR12]\]. Non-targeted biopsy increases the sampling error, resulting in lower sensitivity \[[@CR13]\]. Our biopsy technique may have distorted the MRI results as the immunohistological examination defined the group of patients with myocarditis in our study. The second problem directly following from this procedure is that we classified borderline myocarditis as positive for myocarditis. This milder form of disease may lead to less pronounced changes in the MRI parameters investigated, which also affects our results.

Although we investigated a larger number of patients than both Gutberlet et al. and Abdel-Aty et al., the study is still too small to obtain truly representative statistical data. This is suggested by the measure of quality of logistic regression, the Nagelkerke's R-square, which is 0.127 and thus well below the maximum possible value of nearly 1.

While MRI is quite accurate, shown both in our study and the most important studies \[[@CR14]\] reported in the literature, it should not be used alone to diagnose myocarditis. The final conclusion to be drawn from the results presented here is that all parameters that can be derived from cardiovascular magnetic resonance imaging taken together allow good non-invasive diagnosis of myocarditis with high specificity but have to be supplemented by additional tests for adequate diagnostic management of myocarditis.

Conclusion {#Sec19}
==========

The three parameters used for diagnosing acute myocarditis by MRI---relative oedema, relative enhancement and late enhancement---in part correlate significantly with the presence of myocarditis. Nevertheless, none of the three MRI parameters alone allows one to reliably confirm or rule out disease. The diagnosis can be made with a much higher degree of confidence when all three parameters are used, which specificity. But even the combination of MRI parameters does not allow detection of all cases of the disease, which is why the results should always be interpreted in conjunction with a patient's clinical symptoms, the findings of other diagnostic tests, and not least of all the results of myocardial biopsy.
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